| Original language | English (US) |
|---|---|
| Pages (from-to) | 103-104 |
| Number of pages | 2 |
| Journal | Vaccine |
| Volume | 30 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jan 5 2012 |
Fingerprint
Measles Vaccine
preschool children
Measles
Preschool Children
Developed Countries
developed countries
Newborn Infant
vaccines
ASJC Scopus subject areas
- Immunology and Microbiology(all)
- Infectious Diseases
- Public Health, Environmental and Occupational Health
- veterinary(all)
- Molecular Medicine
Cite this
Poland, G. A., & Jacobson, R. M. (2012). The re-emergence of measles in developed countries: Time to develop the next-generation measles vaccines? Vaccine, 30(2), 103-104. https://doi.org/10.1016/j.vaccine.2011.11.085
The re-emergence of measles in developed countries : Time to develop the next-generation measles vaccines? / Poland, Gregory A.; Jacobson, Robert M.
In: Vaccine, Vol. 30, No. 2, 05.01.2012, p. 103-104.Research output: Contribution to journal › Article
Poland, GA & Jacobson, RM 2012, 'The re-emergence of measles in developed countries: Time to develop the next-generation measles vaccines?', Vaccine, vol. 30, no. 2, pp. 103-104. https://doi.org/10.1016/j.vaccine.2011.11.085
Poland GA, Jacobson RM. The re-emergence of measles in developed countries: Time to develop the next-generation measles vaccines? Vaccine. 2012 Jan 5;30(2):103-104. https://doi.org/10.1016/j.vaccine.2011.11.085
@article{63e97d29ce90480c9f08dae5af3cb584,
title = "The re-emergence of measles in developed countries: Time to develop the next-generation measles vaccines?",
author = "Poland, {Gregory A.} and Jacobson, {Robert M.}",
year = "2012",
month = "1",
day = "5",
doi = "10.1016/j.vaccine.2011.11.085",
language = "English (US)",
volume = "30",
pages = "103--104",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "2",
}
TY - JOUR
T1 - The re-emergence of measles in developed countries
T2 - Time to develop the next-generation measles vaccines?
AU - Poland, Gregory A.
AU - Jacobson, Robert M.
PY - 2012/1/5
Y1 - 2012/1/5
UR - http://www.scopus.com/inward/record.url?scp=84255187518&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84255187518&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2011.11.085
DO - 10.1016/j.vaccine.2011.11.085
M3 - Article
VL - 30
SP - 103
EP - 104
JO - Vaccine
JF - Vaccine
SN - 0264-410X
IS - 2
ER -